Cargando…
Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation
Whilst randomised control trials are undoubtedly the best way to demonstrate whether plasma exchange or infusion alone is the best first-line treatment for patients with atypical haemolytic uremic syndrome (aHUS), individual case reports can provide valuable information. To that effect, we have had...
Autores principales: | Davin, Jean Claude, Strain, Lisa, Goodship, Tim H. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2459233/ https://www.ncbi.nlm.nih.gov/pubmed/18483746 http://dx.doi.org/10.1007/s00467-008-0833-y |
Ejemplares similares
-
Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome
por: Davin, Jean-Claude, et al.
Publicado: (2009) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013) -
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
por: Scully, Marie, et al.
Publicado: (2014) -
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013) -
Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation
por: Davin, Jean-Claude, et al.
Publicado: (2010)